ArticleVirology journal2026
Molecular characterization and phylogenetic analysis of foot-and-mouth disease virus in Nigeria.
Article in Virology journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Foot-and-Mouth Disease (FMD) is a viral disease that affects various cloven-hoofed animals, causing huge economic losses in the livestock sector worldwide. Foot-and-Mouth Disease virus (FMDV), the causative agent of FMD, is recognized to have seven antigenically and immunogenically distinct serotypes, namely, A, O, C, Asia 1, SAT 1, SAT 2, and SAT 3. There are considerable antigenic and genetic diversities within each serotype, resulting in numerous subtypes. This study was aimed at providing updated information on the circulating FMDV strains in Nigeria. We collected 298 epithelial tissue samples aseptically from the oral cavity of cattle suspected of having FMD based on clinical manifestations from December 2023 to November 2024 in representative states of four geopolitical zones in Nigeria. RNA extraction, molecular detection, molecular serotyping, nucleotide sequencing, phylogenetic, and other deep bioinformatic analyses were carried out. Out of the 298 epithelial tissue samples extracted and amplified, a total of 73 (24.5%) samples were positive for FMDV, and 44 (60.3%) were further analyzed. Six out of the 44 samples were sequenced, which, after BLAST analysis, all yielded serotype A, based on VP1 sequences. Phylogenetic analysis placed the study sequences in a distinct cluster separate from the previously reported Nigerian strains, but showed that they evolved from the A/Africa genotype IV topotype. Our analysis also identified a recombinant isolate (PX872163) that shared 97.3% and 93.1% nucleotide identity with PX872165, a major parent, and PX872166, a minor parent, respectively. Five putative B-cell epitopes were identified within the VP1 capsid protein, two of which were localized within the loop regions. In addition, a novel epitope,
Indexed as
Identifiers
42399978What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.